Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease
- 1 August 1988
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 48 (2) , 247-251
- https://doi.org/10.1016/0090-1229(88)90088-8
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Infliximab Treatment for Intravenous Immunoglobulin-resistant Kawasaki Disease: a Multicenter Study in KoreaKorean Circulation Journal, 2019
- Plasma prostaglandin E2 level in Kawasaki diseaseProstaglandins, Leukotrienes & Essential Fatty Acids, 1988
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome.The Journal of Experimental Medicine, 1986
- Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells.The Journal of Immunology, 1986
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.The Journal of Experimental Medicine, 1986
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984
- Pathology of the Heart in Kawasaki DiseasePediatrics, 1978
- Morphological observations on the vasculitis in the mucocutaneous lymph node syndromeEuropean Journal of Pediatrics, 1978